Join a Patient Registry

Patient registries are a cornerstone in advancing new therapies. They are particularly powerful tools for obstacles faced by rare disease communities:

Small patient numbers, incomplete knowledge of the illness, spotty diagnostic expertise and difficulty conducting randomized clinical trials.

A large online SMARCB1-cancer patient database–fully compliant with data protection policies - allows different medical and research centers the world over to collaborate and share data. SMARCB1-cancers are not concentrated in one country.

We must facilitate learning networks and research collaborations between industry, scientific researchers, regulators, clinicians, community organizations, and patients and families. This will :

  • Improve patient care

  • Allow the voices of families and patients to be heard

  • Propel drug development forward

  • Collecting IN ONE PLACE real-world data about SMARCB1-cancerhealth experiences, treatments, clinical careand outcomesisessentialfordriving therapeutic progress

Cassie & Jean-Baptiste Toulouse, Founders© ref de la photo
LOREM IPSUM
Susan Chi

Dui Tellus Arcu Elit Eleifend Sed Purus Id Elit

Over the last decade, cancer research has moved from an anatomic (organ based) perspective to a more transversal molecular understanding.

This is why we need a Patient Registry with all SMARCB1-cancers, from different age groups and different parts of the body. Researchers need this information to find a cure.